PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 63 filers reported holding PROQR THRAPEUTICS N V in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,646 | -19.8% | 17,420 | 0.0% | 0.00% | – |
| Q2 2023 | $28,221 | +17.8% | 17,420 | +54.9% | 0.00% | – |
| Q1 2023 | $23,958 | -53.0% | 11,248 | +77.7% | 0.00% | – |
| Q4 2021 | $51,000 | -44.0% | 6,330 | -53.0% | 0.00% | – |
| Q2 2021 | $91,000 | -22.9% | 13,481 | -24.7% | 0.00% | – |
| Q1 2021 | $118,000 | -47.1% | 17,913 | -53.8% | 0.00% | – |
| Q3 2019 | $223,000 | -36.8% | 38,742 | 0.0% | 0.00% | – |
| Q2 2019 | $353,000 | -26.0% | 38,742 | +12.6% | 0.00% | – |
| Q1 2019 | $477,000 | -28.4% | 34,397 | -18.5% | 0.00% | – |
| Q4 2018 | $666,000 | – | 42,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |